event,time
22 years old ,0
male ,0
admitted to the hospital ,0
mild COVID-19 illness ,-72
sore throat ,-72
loss of sense of smell ,-72
positive COVID-19 PCR ,-72
full recovery ,-40
resolution of symptoms ,-40
negative PCR ,-40
first dose of inactivated SARS-CoV-2 vaccine ,-30
asymptomatic ,-30
second dose of inactivated SARS-CoV-2 vaccine ,0
headache ,2
fatigue ,2
fever ,24
sore throat ,24
abdominal pain ,24
high-grade fever ,96
myalgia ,96
nausea ,96
vomiting ,96
diarrhea ,96
faint erythematous non-itchy rash ,96
dry irritant cough ,96
no shortness of breath ,96
no chest discomfort ,96
no urinary symptoms ,96
no pain or swelling of joints ,96
temperature of 39Â°C ,96
systolic blood pressure of 110 mm Hg ,96
tachycardia ,96
dry mucous membranes ,96
congested throat ,96
bilateral conjunctival injection ,96
left conjunctival hemorrhage ,96
generalised erythematous maculopapular rash ,96
no enlarged peripheral lymph nodes ,96
no audible cardiac murmurs ,96
clear chest ,96
unremarkable abdomen examination ,96
SARS-CoV-2 PCR negative ,96
SARS-CoV-2 IgG positive ,96
throat swab negative for group A streptococcus ,96
sputum culture showed mixed flora ,96
bacterial blood cultures negative ,96
significant proteinuria ,96
ANA negative ,96
dsDNA negative ,96
c-ANCA negative ,96
p-ANCA negative ,96
C3 reduced ,96
C4 reduced ,96
admitted to ICU ,96
treated with ceftriaxone ,96
treated with levofloxacin ,96
intravenous hydrocortisone ,96
haemodynamic stability ,120
discontinued hydrocortisone ,120
persistent fever ,120
facial puffiness ,120
generalised body oedema ,120
tachycardia ,120
diarrhea ,120
myalgia ,120
anasarca ,120
renal impairment ,120
significant proteinuria ,120
ECG showed sinus tachycardia ,120
non-specific T-wave abnormalities ,120
troponin-I raised ,120
pro-BNP raised ,120
severe tricuspid regurgitation ,120
pulmonary hypertension ,120
moderately dilated right atrium and ventricle ,120
normal systolic function ,120
mildly reduced ejection fraction ,120
thin rim of pericardial effusion ,120
bilateral moderate pleural effusion ,120
basal atelectasis ,120
discharged from ICU ,168
treated with dexamethasone ,168
improved ,192
generalised oedema subsided ,192
skin rash resolved ,192
conjunctivitis resolved ,192
white blood cell count normalised ,192
renal function improved ,192
inflammatory markers normalised ,192
repeat echocardiography showed trace tricuspid regurgitation ,192
improved right ventricular systolic function ,192
normal size of right atrium and ventricle ,192
normal pulmonary artery systolic pressure ,192
discharged home ,240
tapering dose of prednisolone ,240
follow-up ,336
symptoms resolved ,336
general weakness ,336
fatigue ,336
repeat echocardiogram normal ,336
